HEALTH● LOWAug 7 · Aug 7, 2026, 5:16 PM
GLP-1 Drug Linked to Heart Benefits for High-Risk Patients
Human Progress
“Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today… A total of 52,971 individuals were included […] The post GLP-1 Drug Linked to Heart Benefits for High-Risk Patients appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH37m agoCollector calls for early breast cancer screening among womenThe HinduHEALTH51m agoExclusive | Soprano alum Max Casella reveals how insane medical condition nearly derailed his careerpagesix.com · United StatesHEALTH1h agoClinical trial saves man initially given weeks to live: "Not done yet"CBS NewsHEALTH2h agoEbola: Uganda restricts transit for travellers from DRCPremium Times